Protective effect of Tetrahydrocurcumin against cisplatin-induced renal damage: In vitro and in vivo studies

Planta Medica

Volumn 81, Issue 4, 2015, Pages 286-291

  Song, Kyung Il ^a   Park, Jun Yeon ^b   Lee, Seungyong ^c,d   Lee, Dahae ^b,d   Jang, Hyuk Jai ^a   Kim, Su Nam ^c   Ko, Hyeonseok ^e   Kim, Hyun Young ^d   Lee, Jae Wook ^c   Hwang, Gwi Seo ^b   Kang, Ki Sung ^b   Yamabe, Noriko ^b  

^a University of Ulsan   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Gyeongsang National University   (South Korea)

^e Catholic Kwandong University   (South Korea)

Author keywords

cisplatin; COX 2; nephrotoxicity; oxidative renal damage; tetrahydrocurcumin

Indexed keywords

CASPASE 3; CISPLATIN; CREATININE; CURCUMIN; CYCLOOXYGENASE 2; ORGANIC CATION TRANSPORTER 2; PROCASPASE 3; SODIUM CHLORIDE; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; CREATININE CLEARANCE; FOOD INTAKE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; KIDNEY CELL; KIDNEY INJURY; KIDNEY MASS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; CURCUMA; DRUG EFFECTS; KIDNEY; KIDNEY DISEASES; LLC PK1 CELL LINE; MALE; METABOLISM; PHYTOTHERAPY; PIG; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BIOMARKERS; CASPASE 3; CISPLATIN; CURCUMA; CURCUMIN; CYCLOOXYGENASE 2; IN VITRO TECHNIQUES; KIDNEY; KIDNEY DISEASES; LLC-PK1 CELLS; MALE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS, WISTAR; SWINE;

EID: 84925465271     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0035-1545696     Document Type: Article

References (36)

1. Cai X. Z., Huang W. Y., Qiao Y., Du S. Y., Chen Y., Chen D., Yu S., Che R. C., Liu N., Jiang Y. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets. Phytomedicine: 2013; 20 495 505
2. Wilken R., Veena M. S., Wang M. B., Srivatsan E. S. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer: 2011; 10 12
3. Hurley L. H. DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer: 2002; 2 188 200
4. Miltenburg N. C., Boogerd W. Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treat Rev: 2014; 40 872 882
5. Chorawala M. R., Oza P. M., Shah G. B. Mechanisms of anticancer drugs resistance: an overview. Int J Pharm Sci Drug Res: 2012; 4 1 9
6. Arany I., Safirstein R. L. Cisplatin nephrotoxicity. Semin Nephrol: 2003; 23 23460 23464
7. Zhu M., Chen J., Yin H., Jiang H., Wen M., Miao C. Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury. Vascul Pharmacol: 2014; 61 72 79
8. Kohn S., Fradis M., Ben-David J., Zidan J., Robinson E. Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findings. Ultrastruct Pathol: 2002; 26 371 382
9. Li Q., Tian Y., Li D., Sun J., Shi D., Lin F., Gao Y., Liu H. The effect of lipocisplatin on cisplatin efficacy and nephrotoxicity in malignant breast cancer treatment. Biomaterials: 2014; 35 6462 6472
10. Luke D. R., Vadiei K., Lopez-Berestein G. Role of vascular congestion in cisplatin induced acute renal failure in the rat. Nephrol Dial Transplant: 1992; 7 1 7
11. Miller R. P., Tadagavadi R. K., Ramesh G., Reeves W. B. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel): 2010; 2 2490 2518
12. Kang K. S., Ham J., Kim Y. J., Park J. H., Cho E. J., Yamabe N. Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism. J Ginseng Res: 2013; 37 379 388
13. Kim J. H., Han I. H., Yamabe N., Kim Y. J., Lee W., Eom D. W., Choi P., Cheon G. J., Jang H. J., Kim S. N., Ham J., Kang K. S. Renoprotective effects of Maillard reaction products generated during heat treatment of ginsenoside Re with leucine. Food Chem: 2014; 15 114 121
14. Lee J. H., Lee W., Lee S., Jung Y., Park S. H., Choi P., Kim S. N., Ham J., Kang K. S. Important role of Maillard reaction in the protective effect of heat-processed ginsenoside Re-serine mixture against cisplatin-induced nephrotoxicity in LLC-PK1 cells. Bioorg Med Chem Lett: 2012; 22 5475 5479
15. Nath K. A., Norby S. M. Reactive oxygen species and acute renal failure. Am J Med: 2000; 109 665 678
16. Taguchi T., Nazneen A., Abid M. R., Razzaque M. S. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol: 2005; 148 107 121
17. Jiang M., Dong Z. Regulation and pathological role of p53 in cisplatin nephrotoxicity. Pharmacology: 2008; 327 300 307
18. Pabla N., Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int: 2008; 73 994 1007
19. Yamabe N., Song K. I., Lee W., Han I. H., Lee J. H., Ham J., Kim S. N., Park J. H., Kang K. S. Chemical and free radical-scavenging activity changes of ginsenoside Re by Maillard reaction and its possible use as a renoprotective agent. J Ginseng Res: 2012; 36 256 262
20. Yamabe N., Kim Y. J., Lee S. Y., Cho E. J., Park S. H., Ham J. Y., Kim H. Y., Kang K. S. Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Maillard reaction. Food Chem: 2013; 138 876 883
21. Huang M. T., Lysz T., Ferraro T., Abidi T. F., Laskin J. D., Conney A. H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res: 1991; 51 813 819
22. Huang M. T., Ma W., Yen P., Xie J. G., Han J., Frenkel K., Grunberger D., Conney A. H. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis: 1997; 18 83 88
23. Sandur S. K., Ichikawa H., Pandey M. K., Kunnumakkara A. B., Sung B., Sethi G., Aggarwal B. B. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med: 2007; 43 568 580
24. Yoysungnoen P., Wirachwong P., Changtam C., Suksamrarn A., Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol: 2008; 7 2003 2009
25. Murugan P., Pari L. Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. Basic Clin Pharmacol Toxicol: 2006; 99 122 127
26. Yokozawa T., Cho E. J., Hara Y., Kitani K. Antioxidative activity of green tea treated with radical initiator 2, 2′-azobis (2-amidinopropane) dihydrochloride. J Agric Food Chem: 2000; 48 5068 5073
27. Forbes J. M., Coughlan M. T., Cooper M. E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes: 2008; 57 1446 1454
28. Heyman S. N., Rosen S., Rosenberger C. A role for oxidative stress. Contrib Nephrol: 2011; 174 138 148
29. Li J. M., Shah A. M. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol: 2003; 14 221 226
30. Takeda H., Sadakane C., Hattori T., Katsurada T., Ohkawara T., Nagai K., Asaka M. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology: 2008; 134 2004 2013
31. Jonker J. W., Schinkel A. H. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther: 2004; 308 2 9
32. Harris R. C. Cyclooxygenase-2 in the kidney. J Cardiovasc Pharmacol: 2006; 47 37 42
33. Kim G. H. Renal effects of prostaglandins and cyclooxygenase-2 inhibitors. Electrolyte Blood Press: 2008; 6 35 41
34. Cohen G. M. Caspases: the executioners of apoptosis. Biochem: 1997; 326 1 16
35. Yang B., Johnson T. S., Thomas G. L., Watson P. F., Wagner B., Nahas A. M. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol: 2001; 12 485 495
36. Mukhopadhyay P., Rajesh M., Pan H., Patel V., Mukhopadhyay B., Bátkai S., Gao B., Haskó G., Pacher P. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med: 2010; 48 457 467